Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEICO: Intralesional Antimony vs Wound Care in Cutaneous Leishmaniasis
NCT00996463Phase 2Completed
- Sponsor
- Waisenmedizin e.V.
- Start
- Jan 2010
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sodium chlorosum in cutaneous leishmaniasis (CL), sponsored by Waisenmedizin e.V. Started Jan 2010; status: completed.
02
Drugs
sodium chlorosum
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT00996463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00996463.